S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AVTX Avalo Therapeutics Inc

8.39

-0.04 (-0.47%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics Inc News

Form 3 - Initial statement of beneficial ownership of securities
Saturday 4 January 2025 (17 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 2 January 2025 (2 days ago) • Edgar (US Regulatory)

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
Thursday 2 January 2025 (2 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 1 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Avalo Therapeutics to Present at Upcoming Investor Conferences
Monday 11 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

More Avalo Therapeutics Inc News Articles

Gold vs US Dollar

S&P ASX 300 Metals and M...

Australian SE All Ordina...

Sterling vs AUD

Commonwealth Bank Of Aus...

Australia And New Zealan...

JP Morgan Chase

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions